CMND

Clearmind Medicine Inc. - Common Shares (CMND)

About Clearmind Medicine Inc. - Common Shares (CMND)

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.

Details

Daily high
$2.43
Daily low
$2.23
Price at open
$2.43
52 Week High
$70.00
52 Week Low
$2.23
Market cap
7.3M
Dividend yield
0.00%
Volume
75,648
Avg. volume
450,871
P/E ratio
-2.70

Clearmind Medicine Inc. - Common Shares News

Details

Daily high
$2.43
Daily low
$2.23
Price at open
$2.43
52 Week High
$70.00
52 Week Low
$2.23
Market cap
7.3M
Dividend yield
0.00%
Volume
75,648
Avg. volume
450,871
P/E ratio
-2.70